ALX Oncology Inc. (ALXO)
NASDAQ: ALXO
· Real-Time Price · USD
1.75
-0.12 (-6.42%)
At close: Sep 29, 2025, 3:59 PM
1.71
-2.29%
After-hours: Sep 29, 2025, 07:26 PM EDT
-6.42% (1D)
| Bid | 1.73 |
| Market Cap | 93.71M |
| Revenue (ttm) | 868K |
| Net Income (ttm) | -116.57M |
| EPS (ttm) | -2.16 |
| PE Ratio (ttm) | -0.81 |
| Forward PE | -1.76 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.79 |
| Volume | 439,766 |
| Avg. Volume (20D) | 953,669 |
| Open | 1.89 |
| Previous Close | 1.87 |
| Day's Range | 1.72 - 1.89 |
| 52-Week Range | 0.40 - 2.05 |
| Beta | 1.12 |
| Ex-Dividend Date | n/a |
About ALXO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALXO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ALXO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
-19.08%
ALX Oncology Holdings shares are trading lower. Th...
Unlock content with
Pro Subscription
6 months ago
+25.96%
ALX Oncology Holdings shares are trading higher after Piper Sandler and Jefferies upgraded their respective price targets on the stock.
1 month ago · seekingalpha.com
ALX Oncology Holdings Inc. (ALXO) Q2 2025 Earnings Call TranscriptALX Oncology Holdings Inc. (NASDAQ:ALXO ) Q2 2025 Earnings Conference Call August 12, 2023 4:30 AM ET Company Participants Alan Bart Sandler - Chief Medical Officer Harish Shantharam - Chief Financial...